Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Tech lifts stocks as poor data rekindles stimulus hopes

Published 09/22/2020, 08:02 PM
Updated 09/23/2020, 08:20 AM
© Reuters. Passersby wearing protective face masks are reflected on a screen displaying stock prices outside a brokerage in Tokyo

By Danilo Masoni

MILAN (Reuters) - Shares rose and the dollar steadied at new highs on Wednesday, with overnight gains by Wall Street tech champions helping balance concerns that new restrictions to counter coronavirus infections will hurt the economic recovery.

Renewed hopes of stimulus measures in Europe also came into play after surveys of private sector economic activity in September painted a gloomy picture for the region, with rising COVID-19 infections leading to a downturn in services.

MSCI's world equity index (MIWD00000PUS), which tracks shares in 49 countries, was 0.3% higher, while the pan-European STOXX 600 (STOXX) benchmark progressively extended opening gains to rise 1.3%.

Technology shares were among the strongest gainers from the start in Europe following a rally overnight in U.S. heavyweights Amazon (O:AMZN), Microsoft (O:MSFT), and Apple (O:AAPL), and a positive performance earlier of peers in Asia. Tech companies have been rare beneficiaries of lockdown measures, with more people working and shopping from home.

A rebound in beaten-down sectors provided extra support.

Nasdaq futures (NQc1) meanwhile built on Tuesday's strong bounce to gain 0.2%. S&P 500 futures (ESc1) were 0.4% higher.

Carlo Franchini, head of institutional sales at Banca Ifigest in Milan, said that despite the gains the underlying mood remained highly cautions given uncertainty linked to the pandemic and its effect on the recovery.

"The U.S. is the only market that's riding on. Investors are interested only in big U.S. tech, even though they should look elsewhere if they took fundamentals into account," he said.

"Cornonavirus is a Damocles' sword for markets. If we continue with uncertainty over a possible vaccine, it's going to be a problem."

UBS Asset Management said on Wednesday that an emergency approval of one to three COVID-19 vaccines was likely in the coming months, a milestone that could finally end the surge of mega-cap U.S. tech stocks.

Purchasing managers' (PMI) surveys showed euro zone activity growth ground to a halt this month, throwing the recovery into question, as fresh restrictions to quell a resurgence in coronavirus infections sent the services industry into reverse.

"It seems a W-shaped economic projection might be developing following the brief bounce in PMI numbers over the summer," said Charles Hepworth, Investment Director at GAM Investments.

"What this means is that continued stimulus across the euro zone will be hopefully forthcoming -- or at least that's what markets are placing their bets on," he added.

In Britain, the recovery from the coronavirus lockdown lost some momentum this month, according to a PMI survey taken before Prime Minister Boris Johnson announced a new round of restrictions that could probably last six months.

Earlier, MSCI's broadest index of Asia-Pacific shares outside Japan (MIAPJ0000PUS) rose 0.3% for its first gain this week, but the mood was hardly bullish. Japan's Nikkei (N225) returned from a two-day holiday to slip 0.1%.

In foreign exchange markets, the standout mover was the dollar, which surged to its highest level since July 27 against a basket of six major currencies (=USD) before paring those gains to trade flat.

"Risk-aversion on the back of new COVID-19 infections affecting Europe more directly remains an important factor this week," UniCredit strategists said in a note.

"This means that the USD is likely to remain firm in its role as preferred safe-haven currency," they added.

The euro (EUR=) was flat after rebounding from a two-month low hit on concerns about coronavirus infections and after the tepid European surveys.

Commodities were weighed down by the robust dollar and worries linked to the economic impact of a second wave of COVID-19.

Gold touched a six-week low as the dollar strengthened. Spot gold was last down 0.3% to $1,893.8 per ounce.

Oil managed to reverse course and turn positive, helped by a report saying U.S. fuel inventories fell.

Brent crude futures (LCOc1) were last up 0.5% at $41.91 a barrel and U.S. crude futures (CLc1) slipped 0.3% to $39.92.

Italy's 30-year bond yield (IT30YT=RR) fell to a record low of 1.76% as the country's debt remained supported after local elections reduced the risk of a snap national poll.

U.S. bonds fell, with the yield on benchmark 10-year U.S. debt up 1.3 basis point at 0.6773%.

© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt

(Additiona reporting by Tom Westbrook in SINGAPORE; Editing by Tomasz Janowski and Catherine Evans)

Latest comments

More Free Stuff please, little concern for debt and printed worrhless paper buying assets, AMAZING
Dollar bullying
wall Street gains were built on what?
Markets is just taking profits. That is all. Otherwise, Gold( a risk-off king) win not suffer this way. Gold in this scenario has much more a currency behavior than a safety haven asset. Btw, what the investors will do with the dollars they are buying? Bet on AMZN? AAPL?
New IPO in Moscow. The company mass produces completed mail in US ballots.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.